Announcing Research 101 | UMR Answers Common Questions About NIH Research in this New Fact Sheet Series
Why Invest in NIH Research? | UMR Offers Fact Sheets Explaining Why Congress Must #keepNIHstrong
Read UMR's Statement on the House Appropriations Committee's Passage of FY23 Labor-HHS Funding Bill
NIH's Role In Sustaining the U.S. Economy | 2022 Update Now Available

A participant in the NIH 2019-2020 Medical Research Scholars Program.

Photo Credit: National Institutes of Health

About This Photo

Promising drug on the horizon for COVID-19

Scientists are reporting promising results for a new drug to treat COVID-19. The drug is known as EIDD-2801. It works by interfering with the coronavirus’ ability to make copies of itself once it infects a cell.

In that regard it’s similar to remdesivir, a drug currently being tested in COVID-19 patients. Researchers from Emory University in Atlanta; the University of North Carolina at Chapel Hill; and Vanderbilt University Medical Center in Nashville, first tested EIDD-2801 in cells cultured in the laboratory.